Sort
8,912 grants matching “sars cov 2”
Nanocrystal Quantum Dot Biomimetics of SARS-CoV-2 to Interrogate Neutrophil-Mediated Neuroinflammation at the Blood-Brain Barrier
$423,500Harris A Gelbard · University Of Rochester · R21 · FY2022 · NS
Genetic and Molecular Basis of Longevity
$423,320Gary B. Ruvkun · Massachusetts General Hospital · R01 · FY2025 · AG
Metabolism-based interactions and organ-targeted delivery of molnupiravir, nirmatrelvir and remdesivir
$423,312Bingfang Yan · University Of Cincinnati · R01 · FY2023 · AI
Mechanisms of long-term taste loss in post-acute sequelae of COVID-19
$423,308Hong Wang · Monell Chemical Senses Center · R01 · FY2022 · DC
Interactions of intrinsically disordered proteins
$422,816Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2025 · EB
Decode the Impact of SARS-CoV-2 on Human Pancreas
$422,571Shuibing Chen · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · DK
Decode the Impact of SARS-CoV-2 on Human Pancreas
$422,571Shuibing Chen · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · DK
Small RNA-mediated warfare between viruses and their hosts
$422,500Paulina Pawlica · Icahn School Of Medicine At Mount Sinai · R35 · FY2024 · GM
Small RNA-mediated warfare between viruses and their hosts
$422,500Paulina Pawlica · Icahn School Of Medicine At Mount Sinai · R35 · FY2025 · GM
Vaccination responses in lung transplant recipients
$422,438Mark Robert Nicolls · Stanford University · U01 · FY2023 · HL
A Rapid and Sensitive Technology for Direct Sensing of Intact SARS-CoV-2 Virions Using Designer DNA Nanostructure Probes and a Smartphone Fluorimeter
$422,226Xing Wang · University Of Illinois At Urbana-Champaign · R21 · FY2021 · EB
The mutational landscape of SARS-CoV-2 nucleocapsid protein
$422,189Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2022 · EB
Pan-cancer Analysis of Convergent Immunoglobulins from Tumor-infiltrating B Cells
$421,685Bin Liu · University Of Tx Md Anderson Can Ctr · R21 · FY2025 · CA
Mechanisms for post-COVID pituitary damage
$421,625Takako Araki · University Of Minnesota · R01 · FY2021 · DK
SARS-CoV-2 Studies
$421,541Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
TMPRSS2 as a potential target for treatments of COVID-19 and respiratory infectious viruses in lung
$421,219Ya-Wen Chen · University Of Southern California · R56 · FY2021 · HL
Self-Assembling Spike-EBR Nanoparticles as a Vaccine Platform Technology Against SARS-CoV-2 and Future Pandemic Coronaviruses.
$421,000Magnus Adrian Gero Hoffmann · California Institute Of Technology · DP5 · FY2022 · OD
Self-Assembling Spike-EBR Nanoparticles as a Vaccine Platform Technology Against SARS-CoV-2 and Future Pandemic Coronaviruses.
$421,000Magnus Adrian Gero Hoffmann · California Institute Of Technology · DP5 · FY2023 · OD
Viral Biosensors of Host Post-Translational Modifications
$420,984Mehdi Bouhaddou · University Of California Los Angeles · R35 · FY2025 · GM
Statistical Approaches to Unlock Protein Function from Deep Mutational Scans
$420,984Harold Pimentel · University Of California Los Angeles · R35 · FY2025 · GM
Validation of Smart Masks for Surveillance of COVID-19
$420,839Jesse Vincent Jokerst · University Of California, San Diego · R01 · FY2023 · DE
Role of Uncharacterized Genes in High Pathogenic Human Coronavirus Infection
$420,831Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI
SARS Replicase Proteins in Pathogenesis and Replication
$420,820Mark R Denison · Univ Of North Carolina Chapel Hill · P01 · FY2009 · AI
virtual compound screening using gene expression
$420,807Bin Chen · Michigan State University · R01 · FY2022 · GM
virtual compound screening using gene expression
$420,807Bin Chen · Michigan State University · R01 · FY2024 · GM